查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1559556

全球肺癌手术市场

Lung Cancer Surgery
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 279 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年全球肺癌手术市场将达83亿美元

2023年全球肺癌手术市场估计为62亿美元，预计在2023-2030年分析期间将以4.2%的复合年增长率增长，并在2030年达到83亿美元。开胸术是本报告分析的细分市场之一，预计复合年增长率为 4.1%，到分析期结束时将达到 58 亿美元。分析期内，微创手术领域的复合年增长率预计为 4.6%。

美国市场预计17亿美元，中国预计复合年增长率6.5%

预计2023年美国肺癌手术市场规模将达17亿美元。中国作为世界第二大经济体，预计2030年市场规模将达18亿美元，2023-2030年分析期间复合年增长率为6.5%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 2.7% 和 3.2%。在欧洲，德国的复合年增长率预计为 3.3%。

全球肺癌手术市场－主要趋势与驱动因素总结

为什么肺癌手术是当今癌症治疗的重要组成部分？

肺癌仍然是世界上最常见和最致命的癌症之一，因此手术等有效的治疗方法对于对抗这种疾病至关重要。肺癌手术涉及切除肿瘤和癌细胞可能扩散的周围肺组织。这种方法通常在肺癌的早期阶段最有效，尤其是非小细胞肺癌（NSCLC），此时肿瘤是局限性的并且可以进行手术。外科技术的进步，包括视讯胸腔镜手术 (VATS) 和机器人辅助手术等微创手术，显着改善了患者的治疗效果。与传统的心臟直视手术相比，这些手术可以减少手术创伤和恢復时间，降低併发症的风险，并提高术后生活品质。随着检测方法的改进以及更多肺癌在可手术阶段被诊断出来，手术在治疗方法中的作用不断扩大。

科技进步如何改变肺癌手术？

由于技术的进步使得手术更加精确和侵入性更小，肺癌手术的环境发生了巨大的变化。机器人手术等创新为外科医生提供了更大的灵活性和控制力，使他们能够进行复杂的解剖并高精度地切除肿瘤，同时保留健康组织。此外，即时电脑断层扫描和萤光成像等术中影像技术提高了肿瘤定位和手术切缘评估的准确性，确保在初次手术期间切除更多的癌组织。这些进步不仅提高了手术介入的成功率，而且最大限度地减少了对患者身体的影响，从而缩短了恢復时间并减少了术后不适。

早期检测和个人化治疗如何影响肺癌手术结果？

早期检测和个人化治疗方法对肺癌手术结果有重大影响。针对高风险族群的低剂量 CT筛检的发展使得肺癌的早期诊断成为可能，现在肺癌通常在可以手术切除并可能治癒的阶段进行诊断。个人化医疗也对肿瘤进行基因分析并了解其特征，以确定哪些患者适合手术以及他们对化疗或标靶治疗等其他治疗的反应如何，我们在这方面取得了巨大进展。这种量身定制的方法有助于制定治疗计划，最大限度地提高手术效果并最大限度地减少不必要的治疗。

肺癌手术市场的成长受到多种因素的推动。

肺癌手术市场的成长受到多种因素的推动，包括技术进步、检测方法的改进以及对个人化医疗的日益重视。微创手术和机器人辅助手术等手术技术的创新正在扩大可手术病例的范围并改善患者的治疗效果，使手术成为许多患者更可行的选择。当手术介入最有利时，加强筛检计画在增加检测到的早期癌症数量方面也发挥着重要作用。此外，随着我们对肺癌遗传基础的了解不断加深，个人化手术治疗变得越来越普遍，从而可以进行更有针对性和更有效的干预措施。这些发展，加上人们对肺癌风险和预防意识的提高，继续推动对肺癌治疗手术解决方案的需求，并反映了一个充满活力和不断发展的市场。

受访企业范例（总合111家）

  • Abbott Molecular, Inc.
  • AbbVie, Inc.
  • Accuray, Inc.
  • Ackermann Instrumente GmbH
  • AngioDynamics, Inc.
  • Baxter International, Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Daiichi Sankyo Co., Ltd.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP13120

Global Lung Cancer Surgery Market to Reach US$8.3 Billion by 2030

The global market for Lung Cancer Surgery estimated at US$6.2 Billion in the year 2023, is expected to reach US$8.3 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. Thoracotomy Procedure, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$5.8 Billion by the end of the analysis period. Growth in the Minimally Invasive Surgery segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.7 Billion While China is Forecast to Grow at 6.5% CAGR

The Lung Cancer Surgery market in the U.S. is estimated at US$1.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 6.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Lung Cancer Surgery Market - Key Trends & Drivers Summarized

Why Is Lung Cancer Surgery a Critical Component of Cancer Treatment Today?

Lung cancer remains one of the most prevalent and deadly cancers worldwide, making effective treatment modalities like surgery crucial in the fight against this disease. Surgery for lung cancer involves the removal of the tumor and surrounding lung tissue where cancer cells may have spread. This approach is generally most effective in the early stages of lung cancer, specifically non-small cell lung cancer (NSCLC), where the tumor is localized and operable. Advances in surgical techniques, including minimally invasive procedures such as video-assisted thoracic surgery (VATS) and robot-assisted surgery, have significantly improved outcomes for patients. These techniques reduce surgical trauma and recovery time, decrease the risk of complications, and can improve the quality of life post-surgery compared to traditional open surgery. As detection methods improve and more lung cancers are diagnosed at an operable stage, the role of surgery in treatment regimens continues to expand.

How Are Technological Advances Transforming Lung Cancer Surgery?

The landscape of lung cancer surgery has been transformed by technological advancements that allow for more precise and less invasive procedures. Innovations such as robotic surgery provide surgeons with enhanced dexterity and control, enabling them to perform complex dissections and remove tumors with high precision while preserving healthy tissue. Furthermore, intraoperative imaging technologies like real-time CT scans and fluorescence imaging have improved the accuracy of tumor localization and the assessment of resection margins, ensuring that more of the cancerous tissue is removed during the initial surgery. These advancements not only increase the success rate of surgical interventions but also minimize the physical impact on patients, leading to faster recovery times and less postoperative discomfort.

What Impact Do Early Detection and Personalized Treatment Have on Lung Cancer Surgery Outcomes?

Early detection and personalized treatment approaches are significantly influencing outcomes in lung cancer surgery. The development of low-dose CT screening for high-risk individuals has led to earlier diagnosis of lung cancer, often at a stage when surgical resection is possible and more likely to be curative. Personalized medicine, which involves genetic profiling of tumors to understand their unique characteristics, has also made strides in determining which patients are good candidates for surgery and how they might best respond to additional treatments such as chemotherapy or targeted therapy. This tailored approach helps in strategizing treatment plans that maximize the efficacy of surgery and minimize unnecessary treatments, thereby improving overall patient survival and quality of life.

Growth in the Lung Cancer Surgery Market Is Driven by Several Factors

The growth in the lung cancer surgery market is driven by several factors, encompassing technological advancements, improved detection methods, and an increased emphasis on personalized medicine. Technological innovations in surgical techniques, including minimally invasive and robotic-assisted surgeries, have broadened the range of operable cases and improved patient outcomes, making surgery a more viable option for many patients. Enhanced screening programs have also played a critical role, as they increase the number of early-stage cancers identified, where surgical intervention can be most beneficial. Additionally, as understanding of the genetic basis of lung cancer improves, personalized surgical treatments are becoming more prevalent, allowing for more targeted and effective interventions. These developments, combined with a growing awareness of lung cancer risks and prevention, continue to drive the demand for surgical solutions in the treatment of lung cancer, reflecting a dynamic and evolving marketplace.

Select Competitors (Total 111 Featured) -

  • Abbott Molecular, Inc.
  • AbbVie, Inc.
  • Accuray, Inc.
  • Ackermann Instrumente GmbH
  • AngioDynamics, Inc.
  • Baxter International, Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Daiichi Sankyo Co., Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Lung Cancer Surgery - Global Key Competitors Percentage Market Share in 2024 (E)
    • Global Economic Update
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Lung Cancer Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Lung Cancer Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Lung Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Thoracotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Thoracotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Thoracotomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Surgical Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Surgical Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Surgical Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Monitoring & Visualizing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Monitoring & Visualizing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Monitoring & Visualizing Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Lung Cancer Surgery Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Minimally Invasive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Minimally Invasive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Minimally Invasive Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Endosurgical Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Endosurgical Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Endosurgical Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • JAPAN
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • CHINA
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • EUROPE
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Lung Cancer Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Lung Cancer Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Lung Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • FRANCE
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • GERMANY
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Lung Cancer Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Lung Cancer Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Lung Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • INDIA
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Lung Cancer Surgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Lung Cancer Surgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Lung Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Lung Cancer Surgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Lung Cancer Surgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Lung Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • AFRICA
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030

IV. COMPETITION